{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:33:02Z","timestamp":1794893582834,"version":"4.9.1"},"reference-count":32,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diffuse large B-cell lymphoma (DLBCL) not otherwise specified is the most common aggressive non-Hodgkin lymphoma and a biologically heterogeneous disease. Despite the development of effective immunotherapies, the organization of the DLBCL tumor-immune microenvironment (TIME) remains poorly understood.We interrogated the intact TIME of 51 de novo DLBCLs with triplicate sampling to characterize 337\u2009995 tumor and immune cells using a 27-plex antibody panel that captured cell lineage, architectural, and functional markers. We spatially assigned individual cells, identified local cell neighborhoods, and established their topographical organization in situ. We found that the organization of local tumor and immune cells can be modeled by 6 composite cell neighborhood types (CNTs). Differential CNT representation divided cases into 3 aggregate TIME categories: immune-deficient, dendritic cell\u2013enriched (DC-enriched), and macrophage-enriched (Mac-enriched). Cases with immune-deficient TIMEs have tumor cell\u2013rich CNTs, in which the few infiltrating immune cells are enriched near CD31+ vessels, in keeping with limited immune activity. Cases with DC-enriched TIMEs selectively include tumor cell\u2013poor\/immune cell\u2013rich CNTs with high numbers of CD11c+ DCs and antigen-experienced T cells also enriched near CD31+ vessels, in keeping with increased immune activity. Cases with Mac-enriched TIMEs selectively include tumor cell\u2013poor\/immune cell\u2013rich CNTs with high numbers of CD163+ macrophages and CD8\u00a0T cells throughout the microenvironment, accompanied by increased IDO-1 and LAG-3 and decreased HLA-DR expression and genetic signatures in keeping with immune evasion. Our findings reveal that the heterogenous cellular components of DLBCL are not randomly distributed but organized into CNTs that define aggregate TIMEs with distinct cellular, spatial, and functional features.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023009813","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T18:13:20Z","timestamp":1684347200000},"page":"4633-4646","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":44,"title":["Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging"],"prefix":"10.1182","volume":"7","author":[{"given":"Kyle T.","family":"Wright","sequence":"first","affiliation":[{"name":"1Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"},{"name":"2Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0556-0616","authenticated-orcid":false,"given":"Jason L.","family":"Weirather","sequence":"additional","affiliation":[{"name":"3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA"},{"name":"4Center for Immuno-oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6149-3142","authenticated-orcid":false,"given":"Sizun","family":"Jiang","sequence":"additional","affiliation":[{"name":"5Department of Microbiology and Immunology, Stanford University, Palo Alto, CA"},{"name":"6Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina Z.","family":"Kao","sequence":"additional","affiliation":[{"name":"4Center for Immuno-oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9636-4164","authenticated-orcid":false,"given":"Yari","family":"Sigal","sequence":"additional","affiliation":[{"name":"7Ionpath Inc, Palo Alto, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2496-7737","authenticated-orcid":false,"given":"Anita","family":"Giobbie-Hurder","sequence":"additional","affiliation":[{"name":"3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3949-6897","authenticated-orcid":false,"given":"Margaret A.","family":"Shipp","sequence":"additional","affiliation":[{"name":"8Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Rodig","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"issue":"20","key":"2023082115442316000_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2023082115442316000_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"2023082115442316000_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"15","key":"2023082115442316000_bib4","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"2023082115442316000_bib5","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","article-title":"Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL","volume":"39","author":"Wilson","year":"2021","journal-title":"Cancer Cell"},{"issue":"SEP","key":"2023082115442316000_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fonc.2018.00351","article-title":"Cancer immunotherapy in diffuse large B-cell lymphoma","volume":"8","author":"Zhang","year":"2018","journal-title":"Front Oncol"},{"issue":"8","key":"2023082115442316000_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"2023082115442316000_bib8","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"8-9","key":"2023082115442316000_bib9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.exger.2005.06.011","article-title":"Tissue microarray technology: principles, pitfalls and perspectives - lessons learned from hematological malignancies","volume":"40","author":"Tzankov","year":"2005","journal-title":"Exp Gerontol"},{"issue":"34","key":"2023082115442316000_bib10","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2008.17.3567","article-title":"A\u00a0decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers","volume":"26","author":"Camp","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"2023082115442316000_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ncponc0046","article-title":"Technology insight: identification of biomarkers with tissue microarray technology","volume":"1","author":"Giltnane","year":"2004","journal-title":"Nat Clin Pract Oncol"},{"issue":"6","key":"2023082115442316000_bib12","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.cell.2018.08.039","article-title":"A\u00a0structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging","volume":"174","author":"Keren","year":"2018","journal-title":"Cell"},{"issue":"5","key":"2023082115442316000_bib13","first-page":"1341","article-title":"Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive","volume":"182","author":"Sch\u00fcrch","year":"2020","journal-title":"Front Cell"},{"issue":"10","key":"2023082115442316000_bib14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2020006464","article-title":"Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell\/histiocyte-rich large B-cell lymphoma","volume":"137","author":"Griffin","year":"2021","journal-title":"Blood"},{"key":"2023082115442316000_bib15","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3389\/fonc.2019.01512","article-title":"Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice","volume":"9","author":"Jayasingam","year":"2019","journal-title":"Front Oncol"},{"issue":"37","key":"2023082115442316000_bib16","doi-asserted-by":"crossref","first-page":"61425","DOI":"10.18632\/oncotarget.18251","article-title":"Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"2023082115442316000_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","article-title":"Coinhibitory pathways in immunotherapy for cancer","volume":"34","author":"Baumeister","year":"2016","journal-title":"Annu Rev Immunol"},{"issue":"7637","key":"2023082115442316000_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"13","key":"2023082115442316000_bib19","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.ejca.2010.06.014","article-title":"Prognostic impact of CD31-positive microvessel density in follicular lymphoma patients treated with immunochemotherapy","volume":"46","author":"Taskinen","year":"2010","journal-title":"Eur J Cancer"},{"issue":"4","key":"2023082115442316000_bib20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/2326-6066.CIR-18-0439","article-title":"Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL","volume":"7","author":"Xu-Monette","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"2023082115442316000_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3324\/haematol.2014.110189","article-title":"Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP","volume":"100","author":"Coutinho","year":"2015","journal-title":"Haematologica"},{"issue":"11","key":"2023082115442316000_bib22","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3109\/10428194.2013.879713","article-title":"An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone","volume":"55","author":"Nam","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2023082115442316000_bib23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-022-01448-2","article-title":"The expanding vistas of spatial transcriptomics","volume":"41","author":"Tian","year":"2023","journal-title":"Nat Biotechnol"},{"issue":"3","key":"2023082115442316000_bib24","doi-asserted-by":"crossref","first-page":"110713","DOI":"10.1016\/j.celrep.2022.110713","article-title":"A\u00a0single-cell atlas of diffuse large B cell lymphoma","volume":"39","author":"Ye","year":"2022","journal-title":"Cell Rep"},{"key":"2023082115442316000_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-2776(05)87005-1","article-title":"The biology of human lymphoid malignancies revealed by gene expression profiling","volume":"87","author":"Staudt","year":"2005","journal-title":"Adv Immunol"},{"issue":"5","key":"2023082115442316000_bib26","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2023082115442316000_bib27","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1158\/2159-8290.CD-20-0839","article-title":"Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures","volume":"11","author":"Kotlov","year":"2021","journal-title":"Cancer Discov"},{"issue":"4","key":"2023082115442316000_bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1158\/1078-0432.CCR-21-3140","article-title":"Clinical impact of immune cells and their spatial interactions in diffuse large B-cell lymphoma microenvironment","volume":"28","author":"Autio","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2023082115442316000_bib29","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3324\/haematol.2019.243626","article-title":"Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma","volume":"106","author":"Autio","year":"2021","journal-title":"Haematologica"},{"issue":"16","key":"2023082115442316000_bib30","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1182\/bloodadvances.2022007493","article-title":"Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma","volume":"6","author":"Colombo","year":"2022","journal-title":"Blood Adv"},{"issue":"8","key":"2023082115442316000_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/blood.2019000847","article-title":"The immune landscape and response to immune checkpoint blockade therapy in lymphoma","volume":"135","author":"Kline","year":"2020","journal-title":"Blood"},{"issue":"19","key":"2023082115442316000_bib32","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1182\/blood.2020007445","article-title":"Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma","volume":"137","author":"Jain","year":"2021","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/16\/4633\/2072524\/blooda_adv-2023-009813-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/16\/4633\/2072524\/blooda_adv-2023-009813-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T11:45:19Z","timestamp":1692618319000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/16\/4633\/495854\/Diffuse-large-B-cell-lymphomas-have-spatially"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":32,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023,8,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023009813","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]}}}